Verofilcon A contact lenses
DeviceInvestigational spherical silicone hydrogel contact lenses for daily disposable wear
Other names: DDT2
NCT Number: NCT03349632
The purpose of this study is to obtain on-eye performance data to inform contact lens product development and to further evaluate product performance in the intended population.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Alcon Investigative Site, Maitland, Florida, United States
The expected duration of subject participation in the study is approximately 20 days with 3 scheduled visits. Each subject will evaluate the test contact lenses compared to 1 of 3 commercially available contact lenses.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Investigational spherical silicone hydrogel contact lenses for daily disposable wear
Other names: DDT2
Commercially available spherical silicone hydrogel contact lenses for daily disposable wear
Other names: ACUVUE OASYS® 1-Day with HydraLuxe™ Technology, Oasys 1-Day
Commercially available spherical silicone hydrogel contact lenses for daily disposable wear
Other names: MyDay®, MyDay
Commercially available spherical silicone hydrogel contact lenses for daily disposable wear
Other names: 1-Day ACUVUE® MOIST, Moist
Time frame: Day 8, each product
Overall quality of vision was collected binocularly and rated on a 10-point scale with 1 = poor to 10 = excellent. Subjects were asked "Thinking back over the last week, please rate our study lenses. Rate eyes together." No formal hypotheses was conducted; hence no inferential testing was performed.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05656027
Eye Diseases, Myopia
Chandler, Arizona, United States
View Trial DetailsNCT05753189
Eye Diseases, Myopia
Dothan, Alabama, United States
View Trial DetailsNCT05728944
Eye Diseases, Myopia
Dothan, Alabama, United States
View Trial DetailsNCT03983278
Eye Diseases, Myopia
Chitrakoot Dham, India
View Trial Details